Prenetics Global Limited (NASDAQ: PRE)
$4.5800
+0.1600 ( -1.08% ) 0.3K
Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
Market Data
Open
$4.5800
Previous close
$4.4200
Volume
0.3K
Market cap
$54.00M
Day range
$4.4950 - $4.6900
52 week range
$2.8500 - $7.8380
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 2 | Oct 15, 2024 |
6-k | Form 6-K | 4 | Oct 07, 2024 |
6-k | Form 6-K | 5 | Sep 27, 2024 |
6-k | Form 6-K | 4 | Sep 16, 2024 |
6-k | Form 6-K | 3 | Aug 19, 2024 |
6-k/a | Form 6-K | 7 | Jul 11, 2024 |
6-k | Form 6-K | 23 | Jul 11, 2024 |
6-k | Form 6-K | 3 | Jul 01, 2024 |
6-k | Form 6-K | 5 | Jun 18, 2024 |
6-k | Form 6-K | 3 | May 21, 2024 |